Compare AANJANEYA LIFECARE with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ALEMBIC PHARMA DR. DATSONS LABS/
ALEMBIC PHARMA
 
P/E (TTM) x -10.9 16.3 - View Chart
P/BV x 0.2 3.7 4.3% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 DR. DATSONS LABS   ALEMBIC PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ALEMBIC PHARMA
Mar-19
DR. DATSONS LABS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs126664 18.9%   
Low Rs31412 7.5%   
Sales per share (Unadj.) Rs133.0208.7 63.7%  
Earnings per share (Unadj.) Rs0.231.0 0.5%  
Cash flow per share (Unadj.) Rs6.637.1 17.8%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs128.8144.2 89.3%  
Shares outstanding (eoy) m31.66188.52 16.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.6 22.8%   
Avg P/E ratio x516.117.4 2,972.6%  
P/CF ratio (eoy) x11.814.5 81.7%  
Price / Book Value ratio x0.63.7 16.3%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m2,477101,461 2.4%   
No. of employees `000NANA-   
Total wages/salary Rs m567,467 0.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21139,347 10.7%  
Other income Rs m7994 83.9%   
Total revenues Rs m4,28939,441 10.9%   
Gross profit Rs m5698,736 6.5%  
Depreciation Rs m2041,152 17.7%   
Interest Rs m430184 233.7%   
Profit before tax Rs m137,493 0.2%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-2-93 1.9%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,568 0.4%   
Profit after tax Rs m55,844 0.1%  
Gross profit margin %13.522.2 60.8%  
Effective tax rate %48.020.9 229.6%   
Net profit margin %0.114.9 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,85219,577 35.0%   
Current liabilities Rs m6,71114,896 45.0%   
Net working cap to sales %3.311.9 28.1%  
Current ratio x1.01.3 77.7%  
Inventory Days Days16190 179.2%  
Debtors Days Days31845 702.2%  
Net fixed assets Rs m3,67327,097 13.6%   
Share capital Rs m317377 84.0%   
"Free" reserves Rs m3,76126,811 14.0%   
Net worth Rs m4,07827,188 15.0%   
Long term debt Rs m1,6714,993 33.5%   
Total assets Rs m12,63347,778 26.4%  
Interest coverage x1.041.7 2.5%   
Debt to equity ratio x0.40.2 223.1%  
Sales to assets ratio x0.30.8 40.5%   
Return on assets %3.412.6 27.3%  
Return on equity %0.121.5 0.5%  
Return on capital %7.723.6 32.5%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96419,453 5.0%   
Fx outflow Rs m6076,065 10.0%   
Net fx Rs m35713,388 2.7%   
CASH FLOW
From Operations Rs m1,3458,120 16.6%  
From Investments Rs m-2,256-7,556 29.9%  
From Financial Activity Rs m-1,200590 -203.2%  
Net Cashflow Rs m-2,1111,153 -183.0%  

Share Holding

Indian Promoters % 4.5 74.1 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.9 -  
FIIs % 1.4 9.1 14.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 13.9 677.0%  
Shareholders   20,807 49,328 42.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS